drugset / Trial / NCT02637323
Study to Characterize the PK and Local Extent and Duration of Exposure From FX006 in Patients With OA of the Knee
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The objectives of this study were to characterize the local extent and duration of exposure of TA from FX006 and TCA IR, characterize the systemic PK of FX006 and TCA IR, and assess the safety and general tolerability of a single 5 mL IA injection of 32 mg FX006 relative to 40 mg of TCA IR in patients with OA of the knee.
Timeline
- Start
- 2015-11
- Primary completion
- 2016-09
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Triamcinolone Acetonide | Other / unclassified | 32 mg | Other |
| Subject | Triamcinolone Acetonide | Other / unclassified | 40 mg | Other |